CDK9 and cancer: This is in line with a recent report on the effects of PIK-75 on acute myeloid leukemia.42 Moreover, we demonstrate that PIK-75's activity to sensitize cancer cells to TRAIL-induced apoptosis is exclusively due to inhibition of CDK9.